Aldesleukin Active Not Recruiting Phase 2 Trials for Stage IIIc Melanoma / Stage IIIA Melanoma / Recurrent Melanoma / Stage IIIB Melanoma / Stage IV Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02203604High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery